Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

Endometrial cancer is a common gynecological cancer with a poor prognosis, mostly attributed to tumor metastasis. Epithelial–mesenchymal transition (EMT) can be mediated via transforming growth factor beta (TGF-β) signaling pathway, facilitating the ability of cancer cell invasion and migration. Iso...

Full description

Bibliographic Details
Main Authors:	Hsin-Yuan Chen, Yi-Fen Chiang, Jia-Syuan Huang, Tsui-Chin Huang, Yin-Hwa Shih, Kai-Lee Wang, Mohamed Ali, Yong-Han Hong, Tzong-Ming Shieh, Shih-Min Hsia
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Cancers
Subjects:	endometrial cancer isoliquiritigenin epithelial–mesenchymal transition transforming growth factor beta metastasis
Online Access:	https://www.mdpi.com/2072-6694/13/6/1236

Similar Items

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
by: Chen Chen, et al.
Published: (2019-10-01)

Perspectives on the Role of Isoliquiritigenin in Cancer
by: Kai-Lee Wang, et al.
Published: (2021-01-01)

Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1/SMAD4 signaling pathway
by: Hsin-Yuan Chen, et al.
Published: (2022-08-01)

The licorice dietary component isoliquiritigenin chemosensitizes human uterine sarcoma cells to doxorubicin and inhibits cell growth by inducing apoptosis and autophagy via inhibition of m-TOR signaling
by: Li-Chun Lin, et al.
Published: (2017-06-01)

Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models
by: Po-Han Lin, et al.
Published: (2020-03-01)

Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation
by: Po-Han Lin, et al.
Published: (2019-08-01)

Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
by: Fen Du, et al.
Published: (2016-11-01)

Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson’s disease by promoting Nrf2/NQO-1 pathway
by: Huang Lijuan, et al.
Published: (2022-09-01)

Protective effect of isoliquiritigenin in amiodarone‐induced damage of human umbilical vein endothelial cells
by: Jin‐Li Guo, et al.
Published: (2023-11-01)

Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity
by: Xiaobo Zhu, et al.
Published: (2019-08-01)

Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
by: Seongtae Jeong, et al.
Published: (2020-08-01)

Effect of particle size on the oral absorption of isoliquiritigenin nanocrystals
by: Yanni Ma, et al.
Published: (2023-01-01)

Isoliquiritigenin Attenuates UUO-Induced Renal Inflammation and Fibrosis by Inhibiting Mincle/Syk/NF-Kappa B Signaling Pathway
by: Liao Y, et al.
Published: (2020-04-01)

Isoliquiritigenin Nanoemulsion Preparation by Combined Sonication and Phase-Inversion Composition Method: In Vitro Anticancer Activities
by: Jianman Wang, et al.
Published: (2022-08-01)

Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models
by: Mahesh Ramalingam, et al.
Published: (2018-11-01)

The protective effect of isoliquiritigenin against doxorubicin-induced nephropathy in rats entails activation of Nrf2 signaling as one key mechanism
by: Wahidah H. Al-Qahtani, et al.
Published: (2022-08-01)

Isoliquiritigenin inhibits apoptosis and ameliorates oxidative stress in rheumatoid arthritis chondrocytes through the Nrf2/HO-1-mediated pathway
by: Shih-Ya Hung, et al.
Published: (2024-01-01)

The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell
by: Tianbao Chen, et al.
Published: (2017-07-01)

Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization
by: Rui Zhang, et al.
Published: (2022-12-01)

Colon-specific delivery of isoliquiritigenin by oral edible zein/caseate nanocomplex for ulcerative colitis treatment
by: Meng Xiao, et al.
Published: (2022-09-01)

Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability
by: Xiaozheng Wu, et al.
Published: (2022-06-01)

Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator
by: Zhu Zhang, et al.
Published: (2022-07-01)

Isoliquiritigenin Enhances the Beige Adipocyte Potential of Adipose-Derived Stem Cells by JNK Inhibition
by: Hanbyeol Moon, et al.
Published: (2020-12-01)

Isoliquiritigenin Alleviates Semen Strychni-Induced Neurotoxicity by Restoring the Metabolic Pathway of Neurotransmitters in Rats
by: Lu Wang, et al.
Published: (2021-11-01)

Network analysis and experimental pharmacology study explore the protective effects of Isoliquiritigenin on 5-fluorouracil-Induced intestinal mucositis
by: Yi-fan Liao, et al.
Published: (2022-10-01)

Isoliquiritigenin inhibits colorectal cancer cells HCT-116 growth by suppressing the PI3K/AKT pathway
by: Huang Ya-Li, et al.
Published: (2017-10-01)

The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer
by: Gang Wang, et al.
Published: (2020-01-01)

Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells
by: Manman Li, et al.
Published: (2022-08-01)

Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling
by: Shijian Xiang, et al.
Published: (2018-08-01)

Isoliquiritigenin Inhibits Gastric Cancer Stemness, Modulates Tumor Microenvironment, and Suppresses Tumor Growth through Glucose-Regulated Protein 78 Downregulation
by: Chien-Hsing Lee, et al.
Published: (2022-06-01)

Long-Circulation and Brain Targeted Isoliquiritigenin Micelle Nanoparticles: Formation, Characterization, Tissue Distribution, Pharmacokinetics and Effects for  Ischemic Stroke
by: Song W, et al.
Published: (2022-08-01)

Isoliquiritigenin Pretreatment Induces Endoplasmic Reticulum Stress-Mediated Hormesis and Attenuates Cisplatin-Induced Oxidative Stress and Damage in LLC-PK1 Cells
by: Tania Gómez-Sierra, et al.
Published: (2020-09-01)

Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
by: Aiqun Liu, et al.
Published: (2023-06-01)

Isoliquiritigenin Protects Neuronal Cells against Glutamate Excitotoxicity
by: Arina Zgodova, et al.
Published: (2022-10-01)

Isoliquiritigenin attenuates non-alcoholic fatty liver disease via the amelioration of hepatic inflammation and autophagy in mice
by: Lina Jian, et al.
Published: (2023-10-01)

Quasi-targeted metabolomics revealed isoliquiritigenin and lauric acid associated with resistance to tobacco black shank
by: Shiwen Peng, et al.
Published: (2024-12-01)

Adenomyosis-derived extracellular vesicles endow endometrial epithelial cells with an invasive phenotype through epithelial-mesenchymal transition
by: Dayong Chen, et al.
Published: (2020-12-01)

Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice
by: Yao D, et al.
Published: (2022-04-01)

Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial–Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway
by: Yifan Wang, et al.
Published: (2023-07-01)

Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE)
by: Hsin-Yuan Chen, et al.
Published: (2021-07-01)